Structural alterations of the erythrocyte membrane proteins in diabetic retinopathy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 8, 2007, Pages 1179-1188

  Petropoulos, Ioannis K ^a   Margetis, Panagiotis I ^b   Antonelou, Marianna H ^b   Koliopoulos, John X ^c   Gartaganis, Sotirios P ^c   Margaritis, Lukas H ^b   Papassideri, Issidora S ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cytoskeletal proteins; Diabetes mellitus; Diabetic retinopathy; Electrophoresis; Erythrocyte membrane proteins; Rheology; Transmembrane proteins

Indexed keywords

CYTOSKELETON PROTEIN; ERYTHROCYTE BAND 3 PROTEIN; GLYCOPHORIN; HEMOGLOBIN; INSULIN; MEMBRANE PROTEIN; SPECTRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; ELECTROPHORETIC MOBILITY; ERYTHROCYTE GHOST; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; VOLUNTEER;

ADULT; AGED; AGED, 80 AND OVER; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROCYTE MEMBRANE; FEMALE; GLYCOPHORIN; HEMORHEOLOGY; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; SPECTRIN;

EID: 34447116866     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0500-6     Document Type: Article

References (48)

1. Adewoye EO, Akinlade KS, Olorunsogo OO (2001) Erythrocyte membrane protein alteration in diabetics. East Afr Med J 78:438-440
2. Advani R, Sorenson S, Shinar E, Lande W, Rachmilewitz E, Schrier SL (1992) Characterization and comparison of the red blood cell membrane damage in severe human alpha- and beta-thalassemia. Blood 79:1058-1063
3. Antonelou MH, Papassideri IS, Karababa FJ, Stravopodis DJ, Loutradi A, Margaritis LH (2003) Defective organization of the erythroid cell membrane in a novel case of congenital anemia. Blood Cells Mol Dis 30:43-54
4. Baba Y, Kai M, Setoyama S, Otsuji S (1978) The lower levels of erythrocyte surface electric charge in diabetes mellitus. Clin Chim Acta 84:247-249
5. Babu N, Singh M (2004) Influence of hyperglycemia on aggregation, deformability and shape parameters of erythrocytes. Clin Hemorheol Microcirc 31:273-280
6. Brown CD, Zhao ZH, De Alvaro F, Chan S, Friedman EA (1993) Correction of erythrocyte deformability defect in ALX-induced diabetic rabbits after treatment with aminoguanidine. Diabetes 42:590-593
7. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321
8. Delaunay J (1998) Disorders of the red cell membrane. In: Lameson JL (ed) Principles of molecular medicine. Humana Press, Totowa, pp 191-195
9. Diabetes Control and Complications Trial Research Group (1995) Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology 102:647-661
10. Dodge JT, Mitchell C, Hanathan DJ (1963) The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 100:119-130
11. Ernst E, Matrai A (1986) Altered red and white blood cell rheology in type II diabetes. Diabetes 35:1412-1415
12. Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:786-806
13. Fairbanks G, Steck TL, Wallach DFH (1971) Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10:2606-2617
14. Frank RN (2004) Diabetic retinopathy. N Engl J Med 350:48-58
15. Fukuda MN (1999) HEMPAS. Hereditary erythroblastic multinuclearity with positive acidified serum lysis test. Biochim Biophys Acta 1455:231-239 231-239
16. Gaczynska M, Judkiewicz L, Szosland K (1993) Abnormal degradation of red cell membrane proteins in diabetes. Cytobios 75:7-11
17. Goldstein M, Leibovitch I, Levin S, Alster Y, Loewenstein A, Malkin G, Korenstein R (2004) Red blood cell membrane mechanical fluctuations in non-proliferative and proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 242:937-943
18. Harik SI, Behmand RA, Arafah BM (1991) Chronic hyperglycemia increases the density of glucose transporters in human erythrocyte membranes. J Clin Endocrinol Metab 72:814-818
19. Hoare EM, Barnes AJ, Dormandy JA (1976) Abnormal blood viscosity in diabetes mellitus and retinopathy. Biorheology 13:21-25
20. Huang SY, Jeng C, Kao SC, Yu JJ, Liu DZ (2004) Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin Nutr 23:615-621
21. Jollow DJ, McMillan DC (2001) Oxidative stress, glucose-6-phosphate dehydrogenase and the red cell. Adv Exp Med Biol 500:595-605
22. Jones GL (1984) Red cell membrane proteins in insulin-dependent diabetes: Differential effects of treatment with calcium and various proteases. Biochem Med 32:398-403
23. Joussen AM, Fauser S, Krohne TU, Lemmen KD, Lang GE, Kirchhof B (2003) Diabetische Retinopathie. Pathophysiologie und Therapie einer hypoxieinduzierten Entzündung. Ophthalmologe 100:363-370
24. Kay MM (1991) Band 3 in aging and neurological disease. Ann N Y Acad Sci 621:179-204
25. Kaymaz AA, Tamer S, Albeniz I, Cefle K, Palanduz S, Ozturk S, Salmayenli N (2005) Alterations in rheological properties and erythrocyte membrane proteins in cats with diabetes mellitus. Clin Hemorheol Microcirc 33:81-88
26. Kirstein M, Brett J, Dadoff S, Ogawa S, Stern D, Vlassara H (1990) Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014
27. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
28. Mazzanti L, Faloia E, Rabini RA, Staffolani R, Kantar A, Fiorini R, Swoboda B, De Pirro R, Bertoli E (1992) Diabetes mellitus induces red blood cell plasma membrane alterations possibly affecting the aging process. Clin Biochem 25:41-46
29. McMillan DC, Powell CL, Bowman ZS, Morrow JD, Jollow DJ (2005) Lipids versus proteins as major targets of pro-oxidant, direct-acting hemolytic agents. Toxicol Sci 88:274-283
30. McMillan DE, Utterback NG, La Puma J (1978) Reduced erythrocyte deformability in diabetes. Diabetes 27:895-901
31. Miller JA, Gravallese E, Bunn HF (1980) Nonenzymatic glycosylation of erythrocyte membrane proteins. Relevance to diabetes. J Clin Invest 65:896-901
32. Palek J, Liu SC, Snyder LM (1978) Metabolic dependence of protein arrangement in human erythrocyte membranes. I. Analysis of spectrin-rich complexes in ATP-depleted red cells. Blood 51:385-395
33. Patz A, Smith RE (1991) The ETDRS and Diabetes 2000. Ophthalmology 98:739-740
34. Raz I, Havivi Y, Yarom R (1998) Reduced negative surface charge on arterial endothelium of diabetic rats. Diabetologia 31:618-620
35. Rettig MP, Low PS, Gimm JA, Mohandas N, Wang J, Christian JA (1999) Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. Blood 93:376-384
36. Rogers ME, Williams DT, Niththyananthan R, Rampling MW, Heslop KE, Johnston DG (1992) Decrease in erythrocyte glycophorin sialic acid content is associated with increased erythrocyte aggregation in human diabetes. Clin Sci 82:309-313
37. Rolo AP, Palmeira CM (2006) Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212:167-178
38. Schwartz RS, Madsen JW, Rybicki AC, Nagel RL (1991) Oxidation of spectrin and deformability defects in diabetic erythrocytes. Diabetes 40:701-708
39. Snyder LM, Fortier NL, Trainor J, Jacobs J, Leb L, Lubin B, Chiu D, Shohet S, Mohandas N (1985) Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrin-hemoglobin cross-linking. J Clin Invest 76:1971-1977
40. Snyder LM, Leb L, Piotrowski J, Sauberman N, Liu SC, Fortier NL (1983) Irreversible spectrin-haemoglobin crosslinking in vivo: A marker for red cell senescence. Br J Haematol 53:379-384
41. Song H, Wang L, Hui Y (2006) Expression of CD18 on the neutrophils of patients with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. DOI 10.1007/s00417-006-0379-2
42. Straface E, Rivabene R, Masella R, Santulli M, Paganelli R, Malorni W (2002) Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes: Protective effects of N-acetylcysteine. Biochem Biophys Res Commun 290:1393-1398
43. Vekasi J, Marton ZS, Kesmarky G, Cser A, Russai R, Horvath B (2001) Hemorheological alterations in patients with diabetic retinopathy. Clin Hemorheol Microcirc 24:59-64
44. Vlassara H, Valinsky J, Brownlee M, Cerami C, Nishimoto S, Cerami A (1987) Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells. J Exp Med 166:539-549
45. Watala C, Witas H, Olszowska L, Piasecki W (1992) The association between erythrocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitus. Int J Exp Pathol 73:655-663
46. Wautier MP, Boulanger E, Guillausseau PJ, Massin P, Wautier JL (2004) AGEs, macrophage colony stimulating factor and vascular adhesion molecule blood levels are increased in patients with diabetic microangiopathy. Thromb Haemost 91:879-885
47. Yamaguchi M, Nakamura N, Nakano K, Kitagawa Y, Shigeta H, Hasegawa G, Ienaga K, Nakamura K, Nakazawa Y, Fukui I, Obayashi H, Kondo M (1998) Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy. Diabet Med 15:458-462
48. Yamamoto T, Kamei M, Yokoi N, Yasuhara T, Tei M, Kinoshita S (2005) Platelet aggregates in various stages of diabetic retinopathy: evaluation using the particle-counting light-scattering method. Graefes Arch Clin Exp Ophthalmol 243:665-670